Mirror Biologics · raw details

Immunomodulatory Vaccines and Immunotherapy Treatments · Jerusalem · Founded 2004

active Series A ← back to profile

Highlights

1 patent

About

Immunomodulatory Vaccines and Immunotherapy Treatments

Mirror Biologics is an international biopharmaceutical company specialized in development and manufacturing of next generation immunotherapy products where the active ingredients are living immune cells. Its technology originally spun out from Hadassah-Hebrew University Medical Center in Jerusalem. The company operates a 21 CFR 1271-compliant blood donor and cell processing center and conduct research and development on the design and testing of novel bioreactors and commercial manufacturing systems.

Its next generation immunotherapy programs aim to harness the power of the human immune system to treat and prevent disease. The company has developed a patented immune cell, called AlloStim®, with powerful immunomodulatory properties that is used to educate and modify a patients’ own immune system to enable it to identify and destroy cancers and infectious organisms and to reprogram immune systems weakened by age or chronic infection.

Its immunomodulatory vaccine development programs are based upon its novel Mirror Effect® technology platform which is able to imprint a re-programmed immune response over an existing failed immune response of a diseased or elderly patient. This novel technology platform expands the indications and type of patients that might benefit from immunotherapy approaches beyond first generation CAR-T and checkpoint inhibitor approaches.

Mirror Biologics acquired all the assets of Immunovative Therapies.

Identity

NameMirror Biologics
Slugmirror-biologics
Former namesImmunovative Therapies
Type / kindstartup
Crunchbase IDimmunovative-therapies
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6Zsc8KDA

Status

Statusactive
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtJerusalem District
HQ cityJerusalem
HQ addressAgudat Sport HaPo'el Road 1, Jerusalem, Israel

Web & social

Websitehttps://www.mirrorbio.com/
Careers pagehttps://www.mirrorbio.com/career-opportunity
LinkedInhttps://www.linkedin.com/company/13180493

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business models
B2B
Tags
biotechnologycancerinfectious-diseasecell-therapyoncologyimmunotherapybiopharmaceuticalimmunologystem-cellspatientspharma-companiesvaccines

Funding

Total raised$42.5M
Current stageSeries A

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}